HEMI device clinical trials

Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease

This study in France looks at how blood vessels work in people with or at risk of kidney disease. It uses two new non-invasive devices, HEMI and SPG-NINOX, to check tiny blood vessels. The goal is to understand changes linked to heart, metabolism, and kidney problems.